Patents by Inventor Cyrille Bicamumpaka

Cyrille Bicamumpaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of paclitaxel, method for producing same and uses thereof
    Patent number: 6391913
    Abstract: The invention relates to new paclitaxel derivatives showing a comparable cytotoxicity of the parent compound, and their uses in a drug targeting therapy. The present invention also relates to the composition and use of such derivative, composition and conjugates for treating cancer.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: May 21, 2002
    Assignee: BCM Development Inc.
    Inventors: Michel Pagé, Cyrille Bicamumpaka, Abdelilah Benosman
  • Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
    Patent number: 5981564
    Abstract: The invention relates to new paclitaxel derivatives showing an increased solubility in water. More particularly, the invention relates to glutarylpaclitaxel, glutarylpaclitaxel 6-aminohexanol glucuronide and to different amino acid derivatives of the glutarylpaclitaxel, all of which possess the cytotoxicity activity of the parent compound, paclitaxel. Also disclosed are fluorescent derivatives of paclitaxel for determining a concentration of paclitaxel in a medium or for detecting apoptotic cancer cells.
    Type: Grant
    Filed: July 1, 1998
    Date of Patent: November 9, 1999
    Assignee: Universite Laval
    Inventors: Michel Page, Renee Paradis, Cyrille Bicamumpaka